Whitepaper: A guide to achieving better insight with accurate data
In today’s modern world, data is everywhere. This eBook will guide you through the steps of how to achieve more with accurate data.
List view / Grid view
In today’s modern world, data is everywhere. This eBook will guide you through the steps of how to achieve more with accurate data.
Quickly and easily quantitate immune checkpoint markers using a fraction of the sample volume required by traditional ELISAs...
In this video, Becky Allsopp from Sygnature Discovery talks about Drug Discovery Research and how she uses the Microplate Reader PHERAstar FSX for their research.
It may be better to examine the urine and the blood of patients suspected of tumours of the plasma cells...
AlphaLISA® provides a robust assay that facilitates the design and development of antibody therapeutics.
The expression of PI3Ky increases during infection by T.cruzi, providing an essential response controlling the parasite and avoiding inflammation...
IGF-1 activated by p38 may be a therapeutic target
New statistical method, ALFRED, could identify predisposition for cancers by using cancer genome data sets to identify risk variants.
This whitepaper explains how you can find ways to optimise the holistic preclinical development process...
Addressing the optimisation of hits derived from a target-agnostic phenotypic screen, using a strategy based on combining bioactivity profiling and reference compound characterisation...
15 June 2018 | By IntelliCyt
The Intellicyt Mouse IgG Type and Titer Kit is a high throughput, multiplexed assay kit that enables analyses of isotype, titer and cell health in a single assay...
Analyse isotype titer and cell health in one assay...
The administration of silibinin in patients with brain metastasis reduces lesions without causing any adverse effects, according to a study led by researchers at the Spanish National Cancer Research Centre (CNIO).
Scientists have deployed a novel genetic screen to search for synthetic viable interactions on special lines of Fanconi Anaemia-defective cells...
For lead optimisation, target-based assays are still the most affordable means of rapidly performing fast iterations and remain core to screening. However, the desire for biological relevance is driving ongoing growth in cell-based assays.